The FLUXNET2015 dataset provides ecosystem-scale data on CO 2 , water, and energy exchange between the biosphere and the atmosphere, and other meteorological and biological measurements, from 212 sites around the globe (over 1500 site-years, up to and including year 2014). These sites, independently managed and operated, voluntarily contributed their data to create global datasets. Data were quality controlled and processed using uniform methods, to improve consistency and intercomparability across sites. The dataset is already being used in a number of applications, including ecophysiology studies, remote sensing studies, and development of ecosystem and Earth system models. FLUXNET2015 includes derived-data products, such as gap-filled time series, ecosystem respiration and photosynthetic uptake estimates, estimation of uncertainties, and metadata about the measurements, presented for the first time in this paper. In addition, 206 of these sites are for the first time distributed under a Creative Commons (CC-BY 4.0) license. This paper details this enhanced dataset and the processing methods, now made available as open-source codes, making the dataset more accessible, transparent, and reproducible.
Prostate cancer is one of the most common cancers in men and the global burden of
this disease is rising. Lifestyle modifications like smoking cessation, exercise and
weight control offer opportunities to decrease the risk of developing prostate cancer.
Early detection of prostate cancer by PSA screening remains controversial; yet, changes in
PSA threshold, frequency of screening, and addition of other biomarkers have potential to
minimise overdiagnosis associated with PSA screening. Several new biomarkers appear
promising in individuals with elevated PSA levels or those diagnosed with prostate cancer,
these are likely to guide in separating individuals who can be spared of aggressive
treatment from those who need it. Several pharmacological agents like 5α-reductase
inhibitors, aspirin etc. have a potential to prevent development of prostate cancer. In
this review, we discuss the current evidence and research questions regarding prevention,
early detection of prostate cancer and management of men either at high risk of prostate
cancer or diagnosed with low-grade prostate cancer.
The knowledge in the field of prostate cancer is rapidly changing. These EAU guidelines on prostate cancer summarize the most recent findings and put them into clinical practice.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.